Global Pelvic Organ Prolapse Repair Market – Industry Trends and Forecast to 2029

Market Analysis and Insights

The market is expected to experience tremendous growth within the forecast period as there is a surge in awareness about women's health and wellness across the globe especially the developing economies which further aids the market to grow at a significant growth.

• Data Bridge Market Research analyses that the pelvic organ prolapse repair market will grow at a CAGR of 3.2% during the forecast period of 2022 to 2029. The “cystocele” accounts for the largest applications segment in the pelvic organ prolapse repair market within the forecasted period.

Market Definition

Pelvic organ prolapse (POP) is basically a type of pelvic floor disorder in which the pelvic tissues and muscles are unable to support the pelvic organs. The damage or weakness of pelvic tissues and muscles is the most common cause of prolapse. It is commonly found in aging female population. 

Pelvic Organ Prolapse Repair Market Dynamics

Drivers

• Growing Cases of Pelvic Organ Prolapse(POP)

The growing prevalence of POP in aging female population and the rising awareness about women's health and wellness will result in the expansion of the growth rate of the treatment market.

Moreover, the increase in healthcare expenditure is also a growth determinant which bolster the growth of the market. Also, the rising concern regarding women’s reproductive health will further enhance the growth of pelvic organ prolapse repair market.

Furthermore, frequent need for treatment and technical advancements in pelvic organ prolapse repair treatments are the factors that will expand the pelvic organ prolapse repair market. Other factors such as increase in the demand for effective treatment procedures coupled with the advancement in medical technology will positively impact the pelvic organ prolapse repair market's growth rate.

Opportunities

Moreover, the increasing investment for the development of advanced and new pelvic organ prolapse repair devices will boost new opportunities for the market's growth rate. Also, the developments in healthcare technology such as the advancements in diagnosis of POP and increasing focus on patient engagement solutions will escalate the growth rate pelvic organ prolapse repair market in future.

Restraints/Challenges

However, the rising complications in post-surgery and vaginal bleeding will impede the growth rate of pelvic organ prolapse repair market. Additionally, the High costs involved in surgeries and high reoccurrence rates owing to lack of effective treatment are estimated to hinder the market’s growth. Dearth of scientific efficacy and safety and regulatory issues are expected to hamper the growth of the market.

This pelvic organ prolapse repair market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on pelvic organ prolapse repair market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The pelvic organ prolapse is type of disorder under which the pelvic tissues and muscles are unable to support the pelvic organs, due to the damage or weakness of pelvic tissues and muscles. Pelvic organ prolapse affects 1.5 to 1.8 women per 1,000 and is most common in women aged 60 to 69. Approximately 50% of the patients of POP are 80 years of age or older, and 37% of the patients are 60-70 years of age.

Pelvic organ prolapse repair market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Pelvic Organ Prolapse Repair Market

Pharmaceutical sector is heavily impacted by the COVID-19. The pelvic organ prolapse repair market was however moderately affected by the sudden emergence of the COVID-19 as many procedures regarding the pelvic organ prolapse were postponed and the COVID patients were the primarily treated across many medical facilities and the implementation of strict lockdowns and isolation regulations across the globe caused lack of access to health-care facilities and even complicated the disease management and medication adherence. Moreover the delays in the import and export of drugs and medicines for the pelvic organ prolapse repair also effected the market. The emergence of the COVID-19 pandemic, on the other hand, has increased the focus on healthcare facilities, teleconsultation, and telemedicine, as well as the burden on the healthcare industry, forcing governments and businesses to invest heavily in order to meet the growing global demand.

Recent Developments

• In March 2020, Fotofinder Zsystems Inc. rebranded automated total body mapping as total body dermoscopy, allowing for immediate evaluation of dermoscopic structures of oles on full body photos.

Global Pelvic Organ Prolapse Repair Market Scope

The pelvic organ prolapse repair market is segmented on the basis of product type, targeted organs, treatment type, applications and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Vaginal Pessary
• Vaginal Mesh

On the basis of product type, pelvic organ prolapse repair market is segmented into vaginal pessary and vaginal mesh.

Targeted Organs

• Bladder
• Vagina
• Uterus
• Small Bowel
• Rectum

On the basis of targeted organs, pelvic organ prolapse repair market is segmented into bladder, vagina, uterus, small bowel and rectum.

Treatment Type

• Surgical
• Non-surgical

On the basis of treatment type, the pelvic organ prolapse repair market is segmented into surgical and non-surgical. Non-surgical is sub-segmented into pessary and pelvic floor muscle therapy. The surgical is sub-segmented into mesh and sutures.

Applications

• Cystocele
• Rectocele
• Enterocele
• Uterine Prolapse
• Others

On the basis of applications, the pelvic organ prolapse repair market is segmented into cystocele, rectocele, enterocele, uterine prolapse and others. Cystocele is projected to show a significant CAGR within the forecasted period.

End User

• Hospitals
• Speciality Clinics
• Nursing Homes
• Ambulatory Surgery Centres
• Others

On the basis of end user, the pelvic organ prolapse repair market is segmented into hospitals, speciality clinics, nursing homes, ambulatory surgery centres and others.

Pelvic Organ Prolapse Repair Market Regional Analysis/Insights

The pelvic organ prolapse repair market is analyzed and market size insights and trends are provided by country, product type, targeted organs, treatment type, applications and end user as referenced above.

The countries covered in the pelvic organ prolapse repair market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the pelvic organ prolapse repair market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising demand of vaginal pessary rings along with prevalence of majority of market players in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the growing number of population along with rising awareness regrading women’s health in the region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Pelvic Organ Prolapse Repair Market Share Analysis

The pelvic organ prolapse repair market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pelvic organ prolapse repair market.

Some of the major players operating in the pelvic organ prolapse repair market are  Johnson & Johnson Services, Inc., Coloplast Pty Ltd, Boston Scientific Corporation, CooperSurgical, Inc., Dr. Arabin GmbH & Co. KG, Integra LifeSciences, , Utah Medical Products, Inc., Tic Med, Cleo, Shenzhen XFT Medical Limited, Sunmedix Co, Ltd., Verity Medical Ltd, Neomedic, and Medtronic among others.

SKU-52612